Your browser doesn't support javascript.
loading
Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy.
Ali, Siraj M; Alpaugh, R Katherine; Downing, Sean R; Stephens, Philip J; Yu, Jian Q; Wu, Hong; Buell, Jamie K; Miller, Vincent A; Lipson, Doron; Palmer, Gary A; Ross, Jeffrey S; Cristofanilli, Massimo.
Afiliación
  • Ali SM; Foundation Medicine, Cambridge, MA.
  • Alpaugh RK; Fox Chase Cancer Center, Philadelphia, PA.
  • Downing SR; Foundation Medicine, Cambridge, MA.
  • Stephens PJ; Foundation Medicine, Cambridge, MA.
  • Yu JQ; Fox Chase Cancer Center, Philadelphia, PA.
  • Wu H; Fox Chase Cancer Center, Philadelphia, PA.
  • Buell JK; Foundation Medicine, Cambridge, MA.
  • Miller VA; Foundation Medicine, Cambridge, MA.
  • Lipson D; Foundation Medicine, Cambridge, MA.
  • Palmer GA; Foundation Medicine, Cambridge, MA.
  • Ross JS; Foundation Medicine, Cambridge, MA; Albany Medical College, Albany, NY.
  • Cristofanilli M; Fox Chase Cancer Center, Philadelphia, PA Massimo.Cristofanilli@Jefferson.edu.
J Clin Oncol ; 32(25): e88-91, 2014 Sep 01.
Article en En | MEDLINE | ID: mdl-24516025

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Neoplasias Inflamatorias de la Mama Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2014 Tipo del documento: Article País de afiliación: Marruecos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Neoplasias Inflamatorias de la Mama Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2014 Tipo del documento: Article País de afiliación: Marruecos
...